Section 5 of DCA : Section 5: The Drugs Technical Advisory Board

Explanation using Example

Imagine a pharmaceutical company has developed a new drug and is seeking approval for its sale in India. Before the drug can be approved, it must be reviewed for safety, efficacy, and quality. The Drugs Technical Advisory Board (DTAB), as constituted under Section 5 of the Drugs and Cosmetics Act, 1940, plays a crucial role in this process.

In this scenario, the DTAB would be called upon to provide technical advice to the Central Government regarding the new drug. The Board, with members like the Director General of Health Services and the Drugs Controller of India, among others, would evaluate the data submitted by the pharmaceutical company. They might also set up a sub-committee with experts to closely examine specific technical aspects of the drug.

Once the DTAB has reviewed the drug and provided its recommendations, the Central Government can make an informed decision on whether to approve the drug for the Indian market, ensuring that the drug is safe for public consumption and meets all regulatory requirements.